Hydroxyurea
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01005 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | female breast carcinoma | KG + DL |
| 2 | hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | KG + DL |
| 3 | sickle cell-beta-thalassemia disease syndrome | KG + DL |
| 4 | sickle cell-hemoglobin d disease syndrome | KG + DL |
| 5 | sickle cell-hemoglobin c disease syndrome | KG + DL |
| 6 | sickle cell-hemoglobin E disease syndrome | KG + DL |
| 7 | cervical adenosarcoma | KG + DL |
| 8 | colon mucinous adenocarcinoma | KG + DL |
| 9 | rectum mucinous adenocarcinoma | KG + DL |
| 10 | gallbladder mucinous adenocarcinoma | KG + DL |
| 11 | cervical carcinosarcoma | KG + DL |
| 12 | cervical mucinous adenocarcinoma | KG + DL |
| 13 | estrogen-receptor positive breast cancer | KG + DL |
| 14 | Ehrlich tumor carcinoma | KG + DL |
| 15 | hormone-resistant breast carcinoma | KG + DL |
| 16 | estrogen-receptor negative breast cancer | KG + DL |
| 17 | extrahepatic bile duct mucinous adenocarcinoma | KG + DL |
| 18 | lung colloid adenocarcinoma | KG + DL |
| 19 | ovarian cystadenocarcinoma | KG + DL |
| 20 | nipple carcinoma | KG + DL |
| 21 | breast carcinoma by gene expression profile | KG + DL |
| 22 | endometrial mucinous adenocarcinoma | KG + DL |
| 23 | rete ovarii adenocarcinoma | KG + DL |
| 24 | bilateral breast carcinoma | KG + DL |
| 25 | Krukenberg carcinoma | KG + DL |
| 26 | relapsing-remitting multiple sclerosis | KG + DL |
| 27 | malignant tumor of meninges | KG + DL |
| 28 | endometrial mixed adenocarcinoma | KG + DL |
| 29 | villoglandular endometrial endometrioid adenocarcinoma | KG + DL |
| 30 | mucin-rich endometrial endometrioid adenocarcinoma | KG + DL |
| 31 | secretory uterine corpus endometrioid adenocarcinoma | KG + DL |
| 32 | spinal cord cancer | KG + DL |
| 33 | adult germ cell tumor | KG + DL |
| 34 | stage I endometrioid carcinoma | KG + DL |
| 35 | stage II endometrioid carcinoma | KG + DL |
| 36 | cerebral neuroblastoma | KG + DL |
| 37 | childhood brain germinoma | KG + DL |
| 38 | cerebellopontine angle embryonal tumor | KG + DL |
| 39 | mediastinal malignant germ cell tumor | KG + DL |
| 40 | enteric pattern testicular yolk sac tumor | KG + DL |
| 41 | testicular yolk sac tumor, hepatoid pattern | KG + DL |
| 42 | testicular yolk sac tumor, papillary pattern | KG + DL |
| 43 | testicular yolk sac tumor, macrocystic pattern | KG + DL |
| 44 | reticular pattern testicular yolk sac tumor | KG + DL |
| 45 | testicular yolk sac tumor, solid pattern | KG + DL |
| 46 | testicular yolk sac tumor, endodermal sinus pattern | KG + DL |
| 47 | polyvesicular vitelline pattern testicular yolk sac tumor | KG + DL |
| 48 | cervical endometrioid adenocarcinoma | KG + DL |
| 49 | central nervous system melanocytic neoplasm | KG + DL |
| 50 | pediatric infratentorial ependymoblastoma | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.